PolyNovo Limited (CALZF)
OTCMKTS · Delayed Price · Currency is USD
0.8000
+0.1044 (15.00%)
Feb 5, 2026, 4:00 PM EST
PolyNovo Market Cap
PolyNovo has a market cap or net worth of $454.86 million as of February 12, 2026. Its market cap has decreased by -51.94% in one year.
Market Cap
454.86M
Enterprise Value
443.15M
Revenue
84.38M
Ranking
n/a
PE Ratio
52.50
Stock Price
$0.80
Market Cap Chart
Since August 23, 1999, PolyNovo's market cap has increased from 21.04M to 454.86M, an increase of 2,061.86%. That is a compound annual growth rate of 12.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 488.50M | -13.81% |
| Dec 31, 2025 | 566.79M | -35.01% |
| Dec 31, 2024 | 872.16M | 12.00% |
| Dec 29, 2023 | 778.69M | -17.56% |
| Dec 30, 2022 | 944.58M | 28.80% |
| Dec 31, 2021 | 733.38M | -62.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OpGen | 340.99M |
| Tian'an Technology Group | 145.66M |
| Zomedica | 127.05M |
| Positron | 68.49M |
| RetinalGenix Technologies | 59.54M |
| CS Diagnostics | 55.94M |
| Vivos | 32.75M |
| Guided Therapeutics | 28.51M |